Patient Demographics and Scan Characteristics
| Characteristics | 68Ga-PSMA | 18F-DCFPyL | 18F-FCH | 18F-FDHT |
| Patient | ||||
| No. of patients | 87 | 50 | 68 | 27 |
| Age (y) | 70 (65–75) | 71 (66–76) | 70 (65–74) | 67 (64–69) |
| Recent PSA (ng/mL) | 4.7 (1.0–16.0) | 7.2 (2.8–17.6) | 9.1 (3.7–39.3) | 28.5 (5.6–112.8) |
| Gleason score | 7 | 7 | 7 | 8 |
| Androgen deprivation treatment | 33% | 8% | 48% | 100% |
| Scan | ||||
| Originating hospitals | AMC; UMCU; St. Antonius | VUmc | VUmc; UMCU | VUmc; MSKCC |
| Inclusion years | 2016, 2017 | 2017, 2018 | 2013–2017 | 2015, 2016 |
| Administered dosage (MBq) | 139.6 (120.2–156.5) | 311.2 (301.6–318.8) | 280.2 (194.0–355.5) | 240.3 (229.9–311.6) |
| Uptake time (min) | 65 (57–74) | 120 (117–123) | 39 (32–45) | 45 (45–47) |
PSA = prostate-specific antigen; AMC = Amsterdam University Medical Centers; UMCU = University Medical Center Utrecht; VUmc = VU University Medical Center; MSKCC = Memorial Sloan Kettering Cancer Center. Data are median values, with interquartile ranges in parentheses.